"Dibenzazepines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds with two BENZENE rings fused to AZEPINES.
| Descriptor ID |
D003984
|
| MeSH Number(s) |
D03.633.300.240
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Dibenzazepines".
Below are MeSH descriptors whose meaning is more specific than "Dibenzazepines".
This graph shows the total number of publications written about "Dibenzazepines" by people in this website by year, and whether "Dibenzazepines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 2 | 0 | 2 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dibenzazepines" by people in Profiles.
-
Mintzer S, Constantino T, Gidal B, Bhargava P, Grinnell T, Blum D. Markers of bone and lipid metabolism with eslicarbazepine acetate monotherapy. Epilepsy Res. 2019 12; 158:106216.
-
Pazdera L, Sperling MR, Harvey JH, Sam MC, Strom LA, Blum D, Grinnell T, Cheng H. Efficacy and safety of eslicarbazepine acetate monotherapy in patients converting from carbamazepine. Epilepsia. 2018 03; 59(3):704-714.
-
Mintzer S, Wechsler RT, Rogin JB, Gidal BE, Schwab M, Ben-Menachem E, Carre?o M, da Silva PS, Moreira J, Li Y, Blum D, Grinnell T. Effects of adjunctive eslicarbazepine acetate on serum lipids in patients with partial-onset seizures: Impact of concomitant statins and enzyme-inducing antiepileptic drugs. Epilepsy Res. 2018 03; 141:83-89.
-
Gidal BE, Mintzer S, Schwab M, Schutz R, Kharidia J, Blum D, Grinnell T, Sunkaraneni S. Evidence for a pharmacokinetic interaction between eslicarbazepine and rosuvastatin: Potential effects on xenobiotic transporters. Epilepsy Res. 2017 09; 135:64-70.
-
Sperling MR, French J, Jacobson MP, Pazdera L, Gough M, Cheng H, Grinnell T, Blum D. Conversion to eslicarbazepine acetate monotherapy: A pooled analysis of 2 phase III studies. Neurology. 2016 Mar 22; 86(12):1095-102.
-
Sperling MR, Harvey J, Grinnell T, Cheng H, Blum D. Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: a randomized historical-control phase III study based in North America. Epilepsia. 2015 Apr; 56(4):546-55.
-
Sperling MR, Abou-Khalil B, Harvey J, Rogin JB, Biraben A, Galimberti CA, Kowacs PA, Hong SB, Cheng H, Blum D, Nunes T, Soares-da-Silva P. Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial-onset seizures: Results of a phase III, double-blind, randomized, placebo-controlled trial. Epilepsia. 2015 Feb; 56(2):244-53.
-
Dunn JP, Muchowski JM, Nelson PH. Antiinflammatory 5,6-dihydro-11-oxodibenz[b,e]azepine-3-acetic acids. J Med Chem. 1981 Sep; 24(9):1097-9.